Cargando…

Performance of a PLK1‐based immune risk model for prognosis and treatment response prediction in breast cancer

OBJECTIVE: Polo‐like kinase 1 (PLK1), a serine/threonine‐protein kinase, functions as a potent oncogene in the initiation and progression of tumor. The aim of this study is to assess potential correlations between PLK1 expression and immune infiltration in breast cancer (BRCA) and construct a PLK1‐b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yan, You, Yiqing, Wu, Qiaoling, Wu, Jing, Lin, Shujing, Sun, Yang, Cui, Zhaolei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225204/ https://www.ncbi.nlm.nih.gov/pubmed/36951624 http://dx.doi.org/10.1002/cam4.5813

Ejemplares similares

Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity
por: Jiang, Shan, et al.
Publicado: (2023)

Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma
por: Fan, Weiqiang, et al.
Publicado: (2022)

Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics
por: Gao, Yang, et al.
Publicado: (2021)

Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma
por: Ye, Qian, et al.
Publicado: (2021)

Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer
por: Liu, Li, et al.
Publicado: (2023)

Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme
por: Xia, Xiangping, et al.
Publicado: (2019)

PLK4 Is a Potential Biomarker for Abnormal Tumor Proliferation, Immune Infiltration, and Prognosis in ccRCC
por: Hu, Chenglu, et al.
Publicado: (2022)

PLK2 modulation of enriched TAp73 affects osteogenic differentiation and prognosis in human osteosarcoma
por: Li, Wenhu, et al.
Publicado: (2020)

Long non-coding RNA HOXA11-AS knockout inhibits proliferation and overcomes drug resistance in ovarian cancer
por: Chen, Yuwei, et al.
Publicado: (2022)

Combination of FOXD1 and Plk2: A novel biomarker for predicting unfavourable prognosis of colorectal cancer
por: Zong, Yaping, et al.
Publicado: (2022)

A novel immune score model predicting the prognosis and immunotherapy response of breast cancer
por: Lv, Wenchang, et al.
Publicado: (2023)

A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer
por: Luo, Jian, et al.
Publicado: (2022)

PLK1 as one novel target for the poor prognosis of bladder cancer: An observational study
por: Liu, Bin, et al.
Publicado: (2022)

PLK1 Inhibition Induces Immunogenic Cell Death and Enhances Immunity against NSCLC
por: Zhou, Jie, et al.
Publicado: (2021)

Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer
por: Lin, Yingying, et al.
Publicado: (2021)

Asterless amplifies Plk4
por: Short, Ben
Publicado: (2015)

FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer
por: Jiang, Shan, et al.
Publicado: (2023)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
por: Li, Jia, et al.
Publicado: (2022)

The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma
por: Zhang, Zhiqi, et al.
Publicado: (2023)

Cancer-testis antigen lactate dehydrogenase C4 in hepatocellular carcinoma: a promising biomarker for early diagnosis, efficacy evaluation and prognosis prediction
por: Cui, Zhaolei, et al.
Publicado: (2020)

Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers
por: Fang, Leiming, et al.
Publicado: (2022)

Construction of a DNA damage repair gene signature for predicting prognosis and immune response in breast cancer
por: Chang, Yiming, et al.
Publicado: (2023)

Bioinformatics analysis of key genes in triple negative breast cancer and validation of oncogene PLK1
por: Ren, Yi, et al.
Publicado: (2020)

A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer
por: Li, Jia, et al.
Publicado: (2022)

High LIN28A and PLK4 co-expression is associated with poor prognosis in epithelial ovarian cancer
por: He, Yao, et al.
Publicado: (2018)

Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
por: Hoffmann, Ingrid
Publicado: (2022)

The lncRNA GATA3-AS1/miR-495-3p/CENPU axis predicts poor prognosis of breast cancer via the PLK1 signaling pathway
por: Lin, Shuangyan, et al.
Publicado: (2021)

A cis‐eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma
por: Meng, Lijuan, et al.
Publicado: (2019)

PLK1 Inhibition alleviates transplant-associated obliterative bronchiolitis by suppressing myofibroblast differentiation
por: Yu, Jizhang, et al.
Publicado: (2020)

Molecular Targeting of the Oncoprotein PLK1 in Pediatric Acute Myeloid Leukemia: RO3280, a Novel PLK1 Inhibitor, Induces Apoptosis in Leukemia Cells
por: Wang, Na-Na, et al.
Publicado: (2015)

Identification of adriamycin resistance genes in breast cancer based on microarray data analysis
por: Chen, Yan, et al.
Publicado: (2020)

Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma
por: Li, Qiaxuan, et al.
Publicado: (2022)

A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients
por: Geng, Shengkai, et al.
Publicado: (2022)

A dynamic model for individualized prognosis prediction in patients with avian influenza A H7N9
por: Zhang, Mingzhi, et al.
Publicado: (2022)

Plk1 in Asthma: Ready for Primetime?
por: Tam, John Kit Chung, et al.
Publicado: (2021)

Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma
por: Ding, Yiming, et al.
Publicado: (2022)

PLK1, A Potential Target for Cancer Therapy
por: Liu, Zhixian, et al.
Publicado: (2016)

Self-regulated mechanism of Plk1 localization to kinetochores: lessons from the Plk1-PBIP1 interaction
por: Lee, Kyung S, et al.
Publicado: (2008)

Pyroptosis-Related lncRNAs Predict the Prognosis and Immune Response in Patients With Breast Cancer
por: Yang, Xia, et al.
Publicado: (2022)

Depths of Malignancy: On the Prognosis of Breast Cancer [Response to Letter]
por: He, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7flhkfcn4trhohj3hl0as8e6a6